Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » NovoSeven RT 50KIU


To avoid
As a precautionary measure

Contraindicated
NovoSeven RT 50KIU :
Type Medicine Authorised
Originator Biotech (NovoSeven RT 50KIU)
Agent Mersaco
Distributor Mersaco
Laboratory Novo Nordisk
Responsible Party Novo Nordisk AS
Origin Denmark
Manufacturer Novo Nordisk AS
Origin Denmark
ATC B02BD08

Your comment will appear shortly after approval


Different Units By MoH Code

Revision Date : 11/01/2013

NovoSeven RT 50KIU  MoH 5540 :
Form Powder and solvent for solution for injection
Packaging Pre-filled Syringes + Vials (Type I glass)
Package Size 1+1
Strength 1mg (50KIU)
Public Price 922866 L.L.
Stratum E1
NSSF
Quarantine
Reg. Number 218019/09
Submission date 01/01/2009
Registration Year 2009





Price Comparison

Country: Italy
Package Size: 1+1x1.1ml
Public Price: 1079.12 EUR ( 104,540,829.12 LBP )
Pack size unit used: 1
Cost/Unit: 1079,12 EUR ( 104,529,204.00 LBP )
Exfactory Price: 653.85 EUR
Pricing Date: 17/12/2019
Type: Medicine Authorised

Country: Qatar
Package Size: 1 powder vial + 1 Solvent pre-filled syringe + vial adapter
Public Price: 3963 QAR ( 97,323,354.00 LBP )
Pack size unit used: 1
Cost/Unit: 3963 QAR ( 97,323,354.00 LBP )
Pharmacy Price: 3255.49386266 QAR ( 79948418.279204 LBP )
Pricing Date: 28/01/2021
Type: Medicine Authorised

Country: Oman
Package Size: 1+1
Public Price: 417.29 OMR ( 96,282,990.86 LBP )
Pack size unit used: 1
Cost/Unit: 417,29 OMR ( 96,216,078.00 LBP )
Pricing Date: 19/02/2021
Type: Medicine Authorised

Country: Switzerland
Package Size: 1+1
Public Price: 907.55 CHF ( 93,858,821.00 LBP )
Pack size unit used: 1
Cost/Unit: 907,55 CHF ( 93,801,940.00 LBP )
Exfactory Price: 845.41 CHF
Pricing Date: 04/04/2021
Type: Medicine Authorised

Country: Kuweit
Package Size: 1+1
Public Price: 319.2 KWD ( 93,711,055.20 LBP )
Pack size unit used: 1
Cost/Unit: 319,2 KWD ( 93,652,339.00 LBP )
Pharmacy Price: 269.67 KWD ( 79169988.27 LBP )
Pricing Date: 07/02/2021
Type: Medicine Authorised

Country: Germany
Package Size: 1
Public Price: 927.81 EUR ( 89,882,521.56 LBP )
Pack size unit used: 1
Cost/Unit: 927,81 EUR ( 89,804,052.00 LBP )
Pricing Date: 24/10/2020
Type: Medicine Authorised

Country: Abu Dhabi
Package Size: 1+1x1.1ml
Public Price: 3703 AED ( 89,468,183.00 LBP )
Pack size unit used: 1
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Pharmacy Price: 3154.78 AED ( 76222639.58 LBP )
Pricing Date: 27/01/2021
Type: Medicine Authorised

Country: UAE
Package Size: 1 Vial (Powder) + 1 Solvent Vial (1.1ml)
Public Price: 3703 AED ( 89,468,183.00 LBP )
Pack size unit used: 1
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Pharmacy Price: 3154.78 AED ( 76222639.58 LBP )
Pricing Date: 21/08/2019
Type: Medicine Authorised

Country: Bahrain
Package Size: 1+1
Public Price: 352.25 BHD ( 83,741,801.50 LBP )
Pack size unit used: 1
Cost/Unit: 352,25 BHD ( 83,682,368.00 LBP )
Reference: nhra
Pricing Date: 09/02/2021
Type: Medicine Authorised

Country: Finland
Package Size: 1+1x1ml
Public Price: 809.89 EUR ( 78,458,903.64 LBP )
Pack size unit used: 1
Cost/Unit: 809,89 EUR ( 78,372,684.00 LBP )
Reference: Kela
Pricing Date: 22/04/2021
Type: Medicine Authorised

Country: Iceland
Package Size: 1+1
Public Price: 110287 ISK ( 71,135,115.00 LBP )
Pack size unit used: 1
Cost/Unit: 110287 ISK ( 71,135,115.00 LBP )
Pharmacy Price: 84672 ISK ( 54613440 LBP )
Reference: Icelandic Medicines Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Denmark
Package Size: 1+1
Public Price: 5318.1 DKK ( 69,007,665.60 LBP )
Pack size unit used: 1
Cost/Unit: 5318,1 DKK ( 69,006,368.00 LBP )
Pharmacy Price: 3948.91 DKK ( 51241056.16 LBP )
Reference: Danish Medicine Agency
Pricing Date: 19/05/2021
Type: Medicine Authorised

Country: Czech Republic
Package Size: 1+1x1ml
Public Price: 17583.04 CZK ( 67,149,629.76 LBP )
Pack size unit used: 1
Cost/Unit: 17583,04 CZK ( 67,149,477.00 LBP )
Reference: SUKL
Pricing Date: 28/02/2020
Type: Medicine Authorised

Country: KSA
Package Size: 1mg
Public Price: 2640 SAR ( 62,409,600.00 LBP )
Pack size unit used: 1
Cost/Unit: 2640 SAR ( 62,409,600.00 LBP )
Reference: sfda
Pricing Date: 16/01/2021
Type: Medicine Authorised

Country: Greece
Package Size: 1+1
Public Price: 642.66 EUR ( 62,258,330.16 LBP )
Pack size unit used: 1
Cost/Unit: 642,66 EUR ( 62,194,392.00 LBP )
Reference: National Organization for Medicines
Pricing Date: 25/03/2019
Type: Medicine Non Marketed

Country: Spain
Package Size: 1 vial + 1xdisolvente
Public Price: 639 EUR ( 61,903,764.00 LBP )
Pack size unit used: 1
Cost/Unit: 639 EUR ( 61,903,764.00 LBP )
Reference: Agencia Española de Medicamentos y Productos Sanitarios
Pricing Date: 06/05/2021
Type: Medicine Non Marketed

Country: UK
Package Size: 1+1
Public Price: 525.2 GBP ( 59,688,454.80 LBP )
Pack size unit used: 1
Cost/Unit: 525,2 GBP ( 59,665,725.00 LBP )
Reference: DMD
Pricing Date: 08/03/2021
Type: Medicine Authorised

Country: France
Package Size: 1+1
Public Price: 608 EUR ( 58,900,608.00 LBP )
Pack size unit used: 1
Cost/Unit: 608 EUR ( 58,900,608.00 LBP )
Reference: ansm
Pricing Date: 15/05/2021
Type: Medicine Authorised

Country: Belgium
Package Size: 1+1x1.1ml
Public Price: 532 EUR ( 51,538,032.00 LBP )
Pack size unit used: 1
Cost/Unit: 532 EUR ( 51,538,032.00 LBP )
Reference: cbip
Pricing Date: 02/12/2020
Type: Medicine Authorised

Country: Norway
Package Size: 1
Public Price: 6048.4 NOK ( 49,016,233.60 LBP )
Pack size unit used: 1
Cost/Unit: 6048,4 NOK ( 49,012,992.00 LBP )
Pharmacy Price: 4715.41 NOK ( 38213682.64 LBP )
Reference: Norwegian Medicine Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Sweden
Package Size: 1+1
Public Price: 5733.56 SEK ( 48,207,772.48 LBP )
Pack size unit used: 1
Cost/Unit: 5733,56 SEK ( 48,203,064.00 LBP )
Pharmacy Price: 5575.79 SEK ( 46881242.32 LBP )
Pricing Date: 23/04/2020
Type: Medicine Authorised

Country: Lebanon
Form: Powder and solvent for solution for injection
Package Size: 1+1
Public Price: 922866 LBP ( 922,866.00 LBP )
Pack size unit used: 1
Cost/Unit: 922866 LBP ( 922,866.00 LBP )
Pricing Date: 13/06/2024

Country: The Netherlands
Package Size: 1
Reference: Zorginstituut Nederland
Pricing Date: 15/06/2019
Type: Medicine Non Marketed

Country: New Zealand
Package Size: 1 inj
Exfactory Price: 1178.3 NZD
Reference: New Zealand Pharmaceutical Management Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Portugal
Package Size: 1+1
Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
Pricing Date: 22/04/2019

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries


Note

Acquired haemophilia : (Adults)
Cost/Unit: 1079,12 EUR ( 104,529,204.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 1079,12 EUR ( 104,529,204.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 1079,12 EUR ( 104,529,204.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 1079,12 EUR ( 104,529,204.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 1079,12 EUR ( 104,529,204.00 LBP )
Cost/Day: 6474,72 EUR ( 627,175,224.00 LBP )
Cost/Month: 6474,72 EUR ( 627,175,224.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 3963 QAR ( 97,323,354.00 LBP )
Cost/Day: 23778 QAR ( 583,940,124.00 LBP )
Cost/Month: 23778 QAR ( 583,940,124.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 3963 QAR ( 97,323,354.00 LBP )
Cost/Day: 23778 QAR ( 583,940,124.00 LBP )
Cost/Month: 23778 QAR ( 583,940,124.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 3963 QAR ( 97,323,354.00 LBP )
Cost/Day: 23778 QAR ( 583,940,124.00 LBP )
Cost/Month: 23778 QAR ( 583,940,124.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 3963 QAR ( 97,323,354.00 LBP )
Cost/Day: 23778 QAR ( 583,940,124.00 LBP )
Cost/Month: 23778 QAR ( 583,940,124.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 3963 QAR ( 97,323,354.00 LBP )
Cost/Day: 23778 QAR ( 583,940,124.00 LBP )
Cost/Month: 23778 QAR ( 583,940,124.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 417,29 OMR ( 96,216,078.00 LBP )
Cost/Day: 2503,74 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,74 OMR ( 577,527,202.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 417,29 OMR ( 96,216,078.00 LBP )
Cost/Day: 2503,74 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,74 OMR ( 577,527,202.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 417,29 OMR ( 96,216,078.00 LBP )
Cost/Day: 2503,74 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,74 OMR ( 577,527,202.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 417,29 OMR ( 96,216,078.00 LBP )
Cost/Day: 2503,74 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,74 OMR ( 577,527,202.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 417,29 OMR ( 96,216,078.00 LBP )
Cost/Day: 2503,74 OMR ( 577,527,202.00 LBP )
Cost/Month: 2503,74 OMR ( 577,527,202.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 907,55 CHF ( 93,801,940.00 LBP )
Cost/Day: 5445,3 CHF ( 563,121,900.00 LBP )
Cost/Month: 5445,3 CHF ( 563,121,900.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 907,55 CHF ( 93,801,940.00 LBP )
Cost/Day: 5445,3 CHF ( 563,121,900.00 LBP )
Cost/Month: 5445,3 CHF ( 563,121,900.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 907,55 CHF ( 93,801,940.00 LBP )
Cost/Day: 5445,3 CHF ( 563,121,900.00 LBP )
Cost/Month: 5445,3 CHF ( 563,121,900.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 907,55 CHF ( 93,801,940.00 LBP )
Cost/Day: 5445,3 CHF ( 563,121,900.00 LBP )
Cost/Month: 5445,3 CHF ( 563,121,900.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 907,55 CHF ( 93,801,940.00 LBP )
Cost/Day: 5445,3 CHF ( 563,121,900.00 LBP )
Cost/Month: 5445,3 CHF ( 563,121,900.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 319,2 KWD ( 93,652,339.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 319,2 KWD ( 93,652,339.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 319,2 KWD ( 93,652,339.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 319,2 KWD ( 93,652,339.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 319,2 KWD ( 93,652,339.00 LBP )
Cost/Day: 1915,2 KWD ( 562,207,615.00 LBP )
Cost/Month: 1915,2 KWD ( 562,207,615.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 927,81 EUR ( 89,804,052.00 LBP )
Cost/Day: 5566,86 EUR ( 539,211,816.00 LBP )
Cost/Month: 5566,86 EUR ( 539,211,816.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 927,81 EUR ( 89,804,052.00 LBP )
Cost/Day: 5566,86 EUR ( 539,211,816.00 LBP )
Cost/Month: 5566,86 EUR ( 539,211,816.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 927,81 EUR ( 89,804,052.00 LBP )
Cost/Day: 5566,86 EUR ( 539,211,816.00 LBP )
Cost/Month: 5566,86 EUR ( 539,211,816.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 927,81 EUR ( 89,804,052.00 LBP )
Cost/Day: 5566,86 EUR ( 539,211,816.00 LBP )
Cost/Month: 5566,86 EUR ( 539,211,816.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 927,81 EUR ( 89,804,052.00 LBP )
Cost/Day: 5566,86 EUR ( 539,211,816.00 LBP )
Cost/Month: 5566,86 EUR ( 539,211,816.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 3703 AED ( 89,468,183.00 LBP )
Cost/Day: 22218 AED ( 536,809,098.00 LBP )
Cost/Month: 22218 AED ( 536,809,098.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 352,25 BHD ( 83,682,368.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 352,25 BHD ( 83,682,368.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 352,25 BHD ( 83,682,368.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 352,25 BHD ( 83,682,368.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 352,25 BHD ( 83,682,368.00 LBP )
Cost/Day: 2113,5 BHD ( 502,331,942.00 LBP )
Cost/Month: 2113,5 BHD ( 502,331,942.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 809,89 EUR ( 78,372,684.00 LBP )
Cost/Day: 4859,34 EUR ( 470,720,484.00 LBP )
Cost/Month: 4859,34 EUR ( 470,720,484.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 809,89 EUR ( 78,372,684.00 LBP )
Cost/Day: 4859,34 EUR ( 470,720,484.00 LBP )
Cost/Month: 4859,34 EUR ( 470,720,484.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 809,89 EUR ( 78,372,684.00 LBP )
Cost/Day: 4859,34 EUR ( 470,720,484.00 LBP )
Cost/Month: 4859,34 EUR ( 470,720,484.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 809,89 EUR ( 78,372,684.00 LBP )
Cost/Day: 4859,34 EUR ( 470,720,484.00 LBP )
Cost/Month: 4859,34 EUR ( 470,720,484.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 809,89 EUR ( 78,372,684.00 LBP )
Cost/Day: 4859,34 EUR ( 470,720,484.00 LBP )
Cost/Month: 4859,34 EUR ( 470,720,484.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 110287 ISK ( 71,135,115.00 LBP )
Cost/Day: 661722 ISK ( 426,810,690.00 LBP )
Cost/Month: 661722 ISK ( 426,810,690.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 110287 ISK ( 71,135,115.00 LBP )
Cost/Day: 661722 ISK ( 426,810,690.00 LBP )
Cost/Month: 661722 ISK ( 426,810,690.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 110287 ISK ( 71,135,115.00 LBP )
Cost/Day: 661722 ISK ( 426,810,690.00 LBP )
Cost/Month: 661722 ISK ( 426,810,690.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 110287 ISK ( 71,135,115.00 LBP )
Cost/Day: 661722 ISK ( 426,810,690.00 LBP )
Cost/Month: 661722 ISK ( 426,810,690.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 110287 ISK ( 71,135,115.00 LBP )
Cost/Day: 661722 ISK ( 426,810,690.00 LBP )
Cost/Month: 661722 ISK ( 426,810,690.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 5318,1 DKK ( 69,006,368.00 LBP )
Cost/Day: 31908,6 DKK ( 414,038,208.00 LBP )
Cost/Month: 31908,6 DKK ( 414,038,208.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 5318,1 DKK ( 69,006,368.00 LBP )
Cost/Day: 31908,6 DKK ( 414,038,208.00 LBP )
Cost/Month: 31908,6 DKK ( 414,038,208.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 5318,1 DKK ( 69,006,368.00 LBP )
Cost/Day: 31908,6 DKK ( 414,038,208.00 LBP )
Cost/Month: 31908,6 DKK ( 414,038,208.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 5318,1 DKK ( 69,006,368.00 LBP )
Cost/Day: 31908,6 DKK ( 414,038,208.00 LBP )
Cost/Month: 31908,6 DKK ( 414,038,208.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 5318,1 DKK ( 69,006,368.00 LBP )
Cost/Day: 31908,6 DKK ( 414,038,208.00 LBP )
Cost/Month: 31908,6 DKK ( 414,038,208.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 17583,04 CZK ( 67,149,477.00 LBP )
Cost/Day: 105498,24 CZK ( 402,896,862.00 LBP )
Cost/Month: 105498,24 CZK ( 402,896,862.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 17583,04 CZK ( 67,149,477.00 LBP )
Cost/Day: 105498,24 CZK ( 402,896,862.00 LBP )
Cost/Month: 105498,24 CZK ( 402,896,862.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 17583,04 CZK ( 67,149,477.00 LBP )
Cost/Day: 105498,24 CZK ( 402,896,862.00 LBP )
Cost/Month: 105498,24 CZK ( 402,896,862.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 17583,04 CZK ( 67,149,477.00 LBP )
Cost/Day: 105498,24 CZK ( 402,896,862.00 LBP )
Cost/Month: 105498,24 CZK ( 402,896,862.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 17583,04 CZK ( 67,149,477.00 LBP )
Cost/Day: 105498,24 CZK ( 402,896,862.00 LBP )
Cost/Month: 105498,24 CZK ( 402,896,862.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 2640 SAR ( 62,409,600.00 LBP )
Cost/Day: 15840 SAR ( 374,457,600.00 LBP )
Cost/Month: 15840 SAR ( 374,457,600.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 2640 SAR ( 62,409,600.00 LBP )
Cost/Day: 15840 SAR ( 374,457,600.00 LBP )
Cost/Month: 15840 SAR ( 374,457,600.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 2640 SAR ( 62,409,600.00 LBP )
Cost/Day: 15840 SAR ( 374,457,600.00 LBP )
Cost/Month: 15840 SAR ( 374,457,600.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 2640 SAR ( 62,409,600.00 LBP )
Cost/Day: 15840 SAR ( 374,457,600.00 LBP )
Cost/Month: 15840 SAR ( 374,457,600.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 2640 SAR ( 62,409,600.00 LBP )
Cost/Day: 15840 SAR ( 374,457,600.00 LBP )
Cost/Month: 15840 SAR ( 374,457,600.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 642,66 EUR ( 62,194,392.00 LBP )
Cost/Day: 3855,96 EUR ( 373,456,980.00 LBP )
Cost/Month: 3855,96 EUR ( 373,456,980.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 642,66 EUR ( 62,194,392.00 LBP )
Cost/Day: 3855,96 EUR ( 373,456,980.00 LBP )
Cost/Month: 3855,96 EUR ( 373,456,980.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 642,66 EUR ( 62,194,392.00 LBP )
Cost/Day: 3855,96 EUR ( 373,456,980.00 LBP )
Cost/Month: 3855,96 EUR ( 373,456,980.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 642,66 EUR ( 62,194,392.00 LBP )
Cost/Day: 3855,96 EUR ( 373,456,980.00 LBP )
Cost/Month: 3855,96 EUR ( 373,456,980.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 642,66 EUR ( 62,194,392.00 LBP )
Cost/Day: 3855,96 EUR ( 373,456,980.00 LBP )
Cost/Month: 3855,96 EUR ( 373,456,980.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 639 EUR ( 61,903,764.00 LBP )
Cost/Day: 3834 EUR ( 371,422,584.00 LBP )
Cost/Month: 3834 EUR ( 371,422,584.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 639 EUR ( 61,903,764.00 LBP )
Cost/Day: 3834 EUR ( 371,422,584.00 LBP )
Cost/Month: 3834 EUR ( 371,422,584.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 639 EUR ( 61,903,764.00 LBP )
Cost/Day: 3834 EUR ( 371,422,584.00 LBP )
Cost/Month: 3834 EUR ( 371,422,584.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 639 EUR ( 61,903,764.00 LBP )
Cost/Day: 3834 EUR ( 371,422,584.00 LBP )
Cost/Month: 3834 EUR ( 371,422,584.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 639 EUR ( 61,903,764.00 LBP )
Cost/Day: 3834 EUR ( 371,422,584.00 LBP )
Cost/Month: 3834 EUR ( 371,422,584.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 525,2 GBP ( 59,665,725.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 525,2 GBP ( 59,665,725.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 525,2 GBP ( 59,665,725.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 525,2 GBP ( 59,665,725.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 525,2 GBP ( 59,665,725.00 LBP )
Cost/Day: 3151,2 GBP ( 358,107,999.00 LBP )
Cost/Month: 3151,2 GBP ( 358,107,999.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 608 EUR ( 58,900,608.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 608 EUR ( 58,900,608.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 608 EUR ( 58,900,608.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 608 EUR ( 58,900,608.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 608 EUR ( 58,900,608.00 LBP )
Cost/Day: 3648 EUR ( 353,403,648.00 LBP )
Cost/Month: 3648 EUR ( 353,403,648.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 532 EUR ( 51,538,032.00 LBP )
Cost/Day: 3192 EUR ( 309,228,192.00 LBP )
Cost/Month: 3192 EUR ( 309,228,192.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 532 EUR ( 51,538,032.00 LBP )
Cost/Day: 3192 EUR ( 309,228,192.00 LBP )
Cost/Month: 3192 EUR ( 309,228,192.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 532 EUR ( 51,538,032.00 LBP )
Cost/Day: 3192 EUR ( 309,228,192.00 LBP )
Cost/Month: 3192 EUR ( 309,228,192.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 532 EUR ( 51,538,032.00 LBP )
Cost/Day: 3192 EUR ( 309,228,192.00 LBP )
Cost/Month: 3192 EUR ( 309,228,192.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 532 EUR ( 51,538,032.00 LBP )
Cost/Day: 3192 EUR ( 309,228,192.00 LBP )
Cost/Month: 3192 EUR ( 309,228,192.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 6048,4 NOK ( 49,012,992.00 LBP )
Cost/Day: 36290,4 NOK ( 294,094,160.00 LBP )
Cost/Month: 36290,4 NOK ( 294,094,160.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 6048,4 NOK ( 49,012,992.00 LBP )
Cost/Day: 36290,4 NOK ( 294,094,160.00 LBP )
Cost/Month: 36290,4 NOK ( 294,094,160.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 6048,4 NOK ( 49,012,992.00 LBP )
Cost/Day: 36290,4 NOK ( 294,094,160.00 LBP )
Cost/Month: 36290,4 NOK ( 294,094,160.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 6048,4 NOK ( 49,012,992.00 LBP )
Cost/Day: 36290,4 NOK ( 294,094,160.00 LBP )
Cost/Month: 36290,4 NOK ( 294,094,160.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 6048,4 NOK ( 49,012,992.00 LBP )
Cost/Day: 36290,4 NOK ( 294,094,160.00 LBP )
Cost/Month: 36290,4 NOK ( 294,094,160.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 5733,56 SEK ( 48,203,064.00 LBP )
Cost/Day: 34401,36 SEK ( 289,243,608.00 LBP )
Cost/Month: 34401,36 SEK ( 289,243,608.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 5733,56 SEK ( 48,203,064.00 LBP )
Cost/Day: 34401,36 SEK ( 289,243,608.00 LBP )
Cost/Month: 34401,36 SEK ( 289,243,608.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 5733,56 SEK ( 48,203,064.00 LBP )
Cost/Day: 34401,36 SEK ( 289,243,608.00 LBP )
Cost/Month: 34401,36 SEK ( 289,243,608.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 5733,56 SEK ( 48,203,064.00 LBP )
Cost/Day: 34401,36 SEK ( 289,243,608.00 LBP )
Cost/Month: 34401,36 SEK ( 289,243,608.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 5733,56 SEK ( 48,203,064.00 LBP )
Cost/Day: 34401,36 SEK ( 289,243,608.00 LBP )
Cost/Month: 34401,36 SEK ( 289,243,608.00 LBP )
Acquired haemophilia : (Adults)
Cost/Unit: 922866 LBP ( 922,866.00 LBP )
Cost/Day: 5537196 LBP ( 5,537,196.00 LBP )
Cost/Month: 5537196 LBP ( 5,537,196.00 LBP )
Congenital FVII deficiency : (Adults)
Cost/Unit: 922866 LBP ( 922,866.00 LBP )
Cost/Day: 5537196 LBP ( 5,537,196.00 LBP )
Cost/Month: 5537196 LBP ( 5,537,196.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX : (Adults)
Cost/Unit: 922866 LBP ( 922,866.00 LBP )
Cost/Day: 5537196 LBP ( 5,537,196.00 LBP )
Cost/Month: 5537196 LBP ( 5,537,196.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII : (Adults)
Cost/Unit: 922866 LBP ( 922,866.00 LBP )
Cost/Day: 5537196 LBP ( 5,537,196.00 LBP )
Cost/Month: 5537196 LBP ( 5,537,196.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA : (Adults)
Cost/Unit: 922866 LBP ( 922,866.00 LBP )
Cost/Day: 5537196 LBP ( 5,537,196.00 LBP )
Cost/Month: 5537196 LBP ( 5,537,196.00 LBP )

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info